A. Tirronen

Cardiac Lymphatics – A New Avenue for Therapeutics?

S. Ylä-Herttuala, T. Vuorio, A. Tirronen, 2017, Trends in Endocrinology & Metabolism.

Recent advances in novel therapies for lipid disorders.

S. Ylä-Herttuala, T. Vuorio, A. Tirronen, 2019, Human molecular genetics.

Intestinal lymphatic vessels and their role in chylomicron absorption and lipid homeostasis.

S. Ylä-Herttuala, A. Tirronen, K. Hokkanen, 2019, Current opinion in lipidology.

Deletion of Lymphangiogenic and Angiogenic Growth Factor VEGF-D Leads to Severe Hyperlipidemia and Delayed Clearance of Chylomicron Remnants

S. Ylä-Herttuala, M. Jauhiainen, M. Kaikkonen, 2018, Arteriosclerosis, thrombosis, and vascular biology.

BMP6/TAZ-Hippo signaling modulates angiogenesis and endothelial cell response to VEGF

S. Ylä-Herttuala, M. Kaikkonen, J. Laakkonen, 2020, Angiogenesis.

The Ablation of VEGFR-1 Signaling Promotes Pressure Overload-Induced Cardiac Dysfunction and Sudden Death

T. Tuomainen, S. Ylä-Herttuala, M. Hedman, 2021, Biomolecules.

BMP6/TAZ-Hippo signaling modulates angiogenesis and endothelial cell response to VEGF

S. Ylä-Herttuala, J. Laakkonen, H. Niskanen, 2020, Angiogenesis.

Finnish Society of Gene and Cell Therapy: A Visionary and Creative Player in the Field.

S. Ylä-Herttuala, A. Tirronen, 2021, Human gene therapy.

Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac Hypertrophy

P. Saharinen, E. Mervaala, Salli Antila, 2024, Circulation research.